Fundz

Laurent Pharmaceuticals Inc. reported raising $2.54 Million in an amended SEC Form D filing

PRIVATEAug 30, 2021

Amount Raised

$2.54 Million

$2.54 Million sold, per SEC Form D (first sale Aug 30, 2021)

Round Type

Seed

MontrealHealthcare

Quick answer

LAURENT PHARMACEUTICALS INC. raised $2.54 Million in a Seed round, dated August 30, 2021. LAURENT PHARMACEUTICALS INC. is based in Montreal, Quebec, Canada.

How much did LAURENT PHARMACEUTICALS INC. raise?
LAURENT PHARMACEUTICALS INC. raised $2.54 Million in a Seed round on August 30, 2021.
What does LAURENT PHARMACEUTICALS INC. do?
Laurent Pharmaceuticals is a private orphan drug company developing a first-in-class oral therapy with potential to modulate the immuno-inflammatory response in cystic fibrosis patients.
Where is LAURENT PHARMACEUTICALS INC. based and how big is it?
LAURENT PHARMACEUTICALS INC. is based in Montreal, Quebec, Canada.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as LAURENT PHARMACEUTICALS INC. that raised within 45 days of this round, from Fundz verified event records.

  • IpiNovyx Bio, Inc. raised $7M on October 14, 2021.
  • Neumentum, Inc. raised $17M on October 14, 2021.
  • Vivante Health, Inc. raised $5.2M on October 14, 2021.
  • Neural Analytics, Inc. raised $10M on October 14, 2021.
  • BAMF HEALTH, LLC raised $5M on October 14, 2021.
  • Elephas raised $20M on October 14, 2021.

Who to call at LAURENT PHARMACEUTICALS INC., and when

A new round usually means LAURENT PHARMACEUTICALS INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day LAURENT PHARMACEUTICALS INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LAURENT PHARMACEUTICALS INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LAURENT PHARMACEUTICALS INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LAURENT PHARMACEUTICALS INC.

Location

1010 SHERBROOKE ST. WEST

Montreal, Quebec, Canada

About

Laurent Pharmaceuticals is a private orphan drug company developing a first-in-class oral therapy with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. Laurent has a clinical stage drug development program (LAU-7b) addressing the compromised immuno-inflammatory response in Cystic Fibrosis (CF), a critical but still enigmatic pathogenic pathway leading to pulmonary insufficiency in CF patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LAURENT PHARMACEUTICALS INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for LAURENT PHARMACEUTICALS INC.'s next move

See what Strategic adds

LAURENT PHARMACEUTICALS INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.